Get started
Work

Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways

Year: 2019
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2019-124178
Authors: Katelyn M. Melgar, LaQuita M Jones, Mackenzie Walker, Lyndsey C Bolanos, Kathleen Hueneman, Mark Wunderlich, Jiang-Kang Jiang, Kelli Wilson, Xiaohu Zhang, Patrick Sutter, Xin Xu, Kwangmin Choi, Gregory Tawa, Donald Lorimer, Jan Abendroth, Eric O'Brien, Scott Hoyt, Ellin Berman, Christopher Famulare, James C Mulloy, Ross L. Levine, Jan S Rosenbaum, John P Perentesis, Craig J Thomas, Daniel T. Starczynowski
Institutions: Cincinnati Children's Hospital Medical Center, National Institutes of Health, National Center for Advancing Translational Sciences, Memorial Sloan Kettering Cancer Center, National Cancer Institute, Center for Cancer Research, University of Cincinnati
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2985896367
Cites:
Cited by: 1
Related to: 10